Table 1 Patient demographics and tumor characteristics
Total (%) | Male (%) | Female (%) | ||
|---|---|---|---|---|
Clinical features | N = 102 | N = 82 | N = 20 | P value |
Sex | ||||
Male | 82 (80.4) | |||
Female | 20 (19.6) | |||
Age (Year) | 0.348 | |||
Median [Range] | 68 [29-86] | 68 [29-84] | 72[29-86] | |
29-49 | 18 (17.6) | 16 (19.5) | 2 (10.0) | |
50-79 | 73 (71.6) | 59 (57.8) | 14 (70.0) | |
79-86 | 11 (10.8) | 7 (8.5) | 4 (20.0) | |
Location | 0.868 | |||
Upper | 27 (26.5) | 22 (26.8) | 5 (33.3) | |
Middle + Lower | 75 (73.5) | 60 (73.2) | 15 (66.6) | |
Operation method | 0.454 | |||
Partial | 64 (62.7) | 50 (61.0) | 14 (70.0) | |
Total | 38 (37.3) | 32 (39.0) | 6 (30.0) | |
Curability | 0.147 | |||
No residual tumors | 87 (85.3) | 72 (87.8) | 15 (75.0) | |
Definite residual tumor | 15 (14.7) | 10 (12,2) | 5 (25.0) | |
Clinical stage (TNM) | 0.563 | |||
Stage I-III | 82 (80.4) | 65 (79.3) | 17 (85.0) | |
Stage IV | 20 (19.6) | 17 (20.7) | 3 (15.0) | |
Histological stage (TNM) | 0.936 | |||
Stage II-III | 86 (84.3) | 69 (84.2) | 17 (85.0) | |
Stage IV | 16 (15.7) | 13 (15.8) | 3 (15.0) | |
Histological type | ||||
Intestinal | 141 (100) | 82 (100) | 20 (100) | |
Diffuse | 0 (0) | 0 (0) | 0 (0) | |
No of LN metastases | 0.013 | |||
Median [Range] | 4 [1-100] | 4 [1-100] | 2 [1-10] |